Yet Another Value Podcast

Artem Fokin, a leading figure at Caro-Kann Capital, discusses investment 'superpowers,' the unique advantages investors can leverage. He delves into sell discipline, explaining when to exit a position based on broken theses, and the psychological resilience required to navigate market volatility. The conversation also highlights the importance of evaluating management teams and the dynamics between microcap versus large-cap investments, providing practical insights for maintaining focus and composure in uncertain times.

A Columbia MBA team discusses their win in the Pershing Square Challenge with a pitch on Carlisle Companies. They delve into the company's competitive advantages, including strong customer relationships and management alignment. Insights from trade show research reveal the importance of personal connections in the industry. The conversation also tackles valuation strategies, market growth projections, and the impact of labor shortages as potential opportunities. Listeners gain a thorough understanding of the dynamics shaping this leading commercial roofing company.

This month, the host dives into post-'Liberation Day' market dynamics and the uncertainty surrounding CEOs. Using sports analogies, he examines how AI is reshaping investor skills and decision-making. He warns about the disconnect between management's sales skills and actual company performance. Discussions also highlight the impact of personal biases on investment choices, illustrating how investments can thrive despite personal indifference. Finally, he addresses the unique risks in biotech investing and the importance of scrutinizing management incentives.

Cliff Sosin of CAS Investment Partners, known for his focused long-term investment style, returns for a compelling discussion. He delves into Carvana's distinctive lending model and the intricacies of subprime finance, revealing misconceptions and opportunities in this sector. The conversation also highlights the impact of alternative data on investment decisions and explores Carvana's operational resilience amidst market challenges. Additionally, Cliff tackles the future of used cars in the age of self-driving technology, making a case for why the traditional ownership model might endure.

Byrne Hobart, writer of The Diff newsletter, brings his expertise on finance, technology, and economics to discuss U.S. trade policy and the book 'Clashing Over Commerce.' He highlights how tariffs have shaped American politics and examines the complex relationship between protectionism and free trade. The conversation touches on historical insights from the Civil War to modern supply chains, the evolution of tariff authority, and the political dynamics influencing trade decisions today. Hobart's unique perspectives offer a captivating look at how history informs contemporary economic debates.

Join Thomas Li, CEO and co-founder of Daloopa, as he unpacks how AI is reshaping the investment landscape. He discusses the strengths and challenges of AI in finance, emphasizing its applications in hedge funds and banks. Key insights include the significance of contextual data over mere algorithm quality and the variations in AI adoption between large and small firms. Thomas also highlights how generational perspectives influence attitudes towards AI's role, blending technology's efficiency with critical human judgment.

Andrew goes solo, sharing insights on the surprising corporate moves at KROS and the investor skepticism in the biotech sector. He critiques the industry's structural inefficiencies and emphasizes the need for stronger corporate governance. The conversation turns to the pitfalls of stock-based compensation in falling markets. He reflects on maintaining mental discipline in turbulent times and highlights the evolving role of AI in investment research, urging listeners to enhance their analytical toolkit.

Delve into the tumultuous world of Keros Therapeutics, where hope dwindles after halted trials for their drug Cybo. The discussion highlights the risks of becoming a 'zombie biotech' due to misaligned incentives between management and shareholders. A pivotal licensing deal with Takeda emerges as a potential lifeline, while skepticism looms over the future of drugs 065 and O12. Explore strategic options that could enhance shareholder value and the importance of effective governance in navigating these challenging waters.

Marc Chalfin, an investor at Windward Capital, dives into the intricate world of Turtle Beach, a leader in gaming peripherals. He highlights the company's strategic acquisition of PDP and how upcoming game releases like GTA VI could influence its growth. Chalfin discusses Turtle Beach's robust buyback strategy, navigating supply chain hurdles, and the competitive landscape against firms like Logitech. His insights shed light on potential exits, making a compelling case for Turtle Beach's future in the gaming market.

Adam Patinkin of David Capital joins to provide an insights-packed update on Vistry, a British homebuilder. He delves into the challenges Vistry faced this year, including profit warnings, yet argues that the company's fundamentals remain strong. With recent strategic shifts towards a pure-play partnerships model, Patinkin explains why David Capital doubled its position in Vistry. He also highlights the alignment between UK government policies and Vistry’s strategy, sparking optimism for future growth despite current market hurdles.